Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Zehentmayr, Franz und Karner, Josef und Stana, Markus und Ruznic, Elvis und Zellinger, Barbara und Klebermass, Marisa und Purevdorj, Ayurzana und Gruber, Georg und Minasch, Danijela und Heilmann, Martin und Moosbrugger, Raphaela und Roeder, Falk und Grambozov, Brane (2025) Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR). Medical sciences (Basel, Switzerland), 13 (4). ISSN 2076-3271

Vorschau

Text
medsci-13-00305.pdf
Herunterladen (1MB) | Vorschau

Eintrag bearbeiten